Replimune Group, Inc.
For the period ended Mar 31, 2025. Filed May 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 22, 2025
REPL$23.28+4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of cash flows F-
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
| Year Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(247,297) | $(215,794) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation expense | 35,044 | 34,125 |
| Depreciation and amortization | 3,502 | 2,655 |
| Net amortization of premiums and discounts on short-term investments | (8,947) | (12,326) |
| Noncash interest expense | 1,568 | 1,161 |
| Unrealized foreign currency transaction losses | (201) | (771) |
| Changes in operating assets and liabilities: | ||
| Research and development incentives receivable | 1,303 | (1,916) |
| Prepaid expenses and other current assets | (252) | (1,778) |
| Operating lease, right-of-use-asset | 683 | 615 |
| Finance lease, right-of-use-asset | 2,428 | 2,428 |
| Other non-current assets | (1,200) | — |
| Accounts payable | 9,941 | (2,794) |
| Accrued expenses and other current liabilities | 11,743 | 9,234 |
| Operating lease liabilities | (720) | (620) |
| Other non-current liabilities | 155 | 314 |
| Net cash used in operating activities | (192,250) | (185,467) |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment and software capitalization | (6,687) | (5,662) |
| Purchase of short-term investments | (403,586) | (489,516) |
| Proceeds from sales and maturities of short-term investments | 386,477 | 592,379 |
| Net cash (used in) provided by investing activities | (23,796) | 97,201 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock, net of underwriting fees and offering costs | 155,728 | — |
| Proceeds from issuance of prefunded warrants to purchase common stock, net of underwriting fees and offering costs | 97,000 | — |
| Proceeds from long-term debt | — | 15,000 |
| Principal payment of finance lease obligation | (599) | (476) |
| Proceeds from exercise of stock options | 267 | 1,759 |
| Net cash provided by financing activities | 252,396 | 16,283 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 315 | (86) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 36,665 | (72,069) |
| Cash, cash equivalents and restricted cash at beginning of period | 76,157 | 148,226 |
| Cash, cash equivalents and restricted cash at end of period | $112,822 | $76,157 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid during the period for interest | 4,198 | $3,044 |
| Cash paid for income taxes | 105 | 300 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Purchases of property and equipment included in accounts payable | $171 | $101 |
F - 8
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.